These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 14595724)
1. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia. Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724 [No Abstract] [Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849 [TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms. Guo CY; Halton JM; Barr RD; Atkinson SA Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment. Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115 [TBL] [Abstract][Full Text] [Related]
5. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213 [TBL] [Abstract][Full Text] [Related]
7. Low bone mineral density in childhood acute lymphoblastic leukemia. Naithani R; Desai A Indian Pediatr; 2009 Jun; 46(6):542-3; author reply 543-4. PubMed ID: 19556673 [No Abstract] [Full Text] [Related]
8. Evaluation of bone metabolism in children with acute lymphoblastic leukemia. A 2-year study from Northern Greece. Tragiannidis A; Athanassiadou F; Rousso I; Karamouzis M; Katzos G; Tsitouridis I; Sidi V; Koliouskas D J Pediatr Hematol Oncol; 2006 Oct; 28(10):699. PubMed ID: 17023835 [No Abstract] [Full Text] [Related]
9. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587 [TBL] [Abstract][Full Text] [Related]
10. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756 [TBL] [Abstract][Full Text] [Related]
11. [Progeny of women after intensive treatment of acute lymphoblastic leukemia in childhood]. Radwańska U; Kaczmarek M; Michalewska D; Barczyk K Pediatr Pol; 1988 Nov; 63(11):753-8. PubMed ID: 3253662 [No Abstract] [Full Text] [Related]
12. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786 [TBL] [Abstract][Full Text] [Related]
13. [21 years in the treatment of acute lymphoblastic leukemias in children (1967-1987)]. Ortega JJ; Javier G; Olivé T; Montagut JM Sangre (Barc); 1988 Oct; 33(5):372-82. PubMed ID: 3073534 [No Abstract] [Full Text] [Related]
14. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia. Laughton SJ; Ashton LJ; Kwan E; Norris MD; Haber M; Marshall GM J Clin Oncol; 2005 Apr; 23(10):2264-71. PubMed ID: 15800317 [TBL] [Abstract][Full Text] [Related]
15. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M; Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521 [TBL] [Abstract][Full Text] [Related]
16. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia and its association with mineral homeostasis and duration of inpatient stay. Elmantaser ME; Young D; Gibson B; Ahmed SF J Pediatr Hematol Oncol; 2011 Oct; 33(7):516-20. PubMed ID: 21941144 [TBL] [Abstract][Full Text] [Related]
17. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia. Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718 [TBL] [Abstract][Full Text] [Related]
18. [Acute encephalopathy during treatment of lymphoblastosis in children]. Jean R; Navarro M; Marty M; Dossa D; Margueritte G; Montoya F; Maury M Ann Pediatr (Paris); 1976 Dec; 23(12):789-95. PubMed ID: 16106898 [No Abstract] [Full Text] [Related]
19. Evaluation of bone mineral density at different phases of therapy of childhood all. Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407 [TBL] [Abstract][Full Text] [Related]